FDA Drug Application (202611) for MYRBETRIQ by APGDI

Back to FDA Applications sponsored by APGDI

Application Number202611
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameMYRBETRIQ
Active IngredientMIRABEGRON



Back to FDA Applications sponsored by APGDI

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.